Top Tech Companies (2,062)
Don't see your company?
Create a company profile
We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes.
As the world's largest fully integrated producer of PA66, we designed our vertically integrated manufacturing process to ensure quality, consistency and supply security. Headquartered in Houston, Texas, Ascend has nine global locations, including five fully integrated manufacturing facilities in the southeastern United States and an engineering plastics compounding facility in Europe, all dedicated to the innovation and safe production of nylon 6,6. With three of the world's largest chemical processing facilities, Ascend's materials form the building blocks for products used in everyday applications from apparel to airbags, cable ties to circuit boards and carpets to car parts. Ascend's 2,500 employees around the world are committed to making a difference in the communities we serve and leading the development of nylon 6,6 solutions that inspire everyone, everywhere, every day. Together, we're making a difference. Together, we're inspiring everyday.
Refocus Group is a medical device company engaged in the research and development of treatments for human vision disorders.
Creating fully human monoclonal antibodies that target and neutralize HIV and other infectious diseases.
Madison Core Laboratories (MCL) is a state-of-the-art full service locally based independent clinical laboratory. Our clients include physician offices, long-term care facilities, assisted living facilities, homebound patients, addiction clinics, and industrial/corporate testing needs. MCL is one of the leading independent laboratories in Alabama. We provide extensive laboratory services using state-of-the art testing equipment to provide our clients with the latest innovations in the laboratory spectrum. We provide mobile services, rapid courier pickups, timely, and accurate results. MCL placed 123rd on the 2022 Inc. Magazine’s list of fastest-growing companies in the Southeast. Our main facility is in Huntsville, Alabama which has been named the Number 1 Best Place to Live by U.S. News & World Report for 2022-2023.
.jpg)
SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. With strategic scientific consulting and clinical data services (biostatistics, data management/EDC, and IRT/IWRS) expertise at our core, our services are scalable via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC is The Right Fit For You.®
GlucanBio, an early stage company that repurposes non-food biomass into high-value chemicals and biomaterials
Cook MyoSite is on a mission to make regenerative medicine a part of everyday medicine. As an industry leader in muscle cell technology, we’re establishing new paradigms for muscle-related disorders. Established in 2002, Cook MyoSite was created to guide the Cook Group organization into the expanding world of cellular technologies. We’re proud to be a part of the vibrant medical community in Pittsburgh, Pennsylvania.
Ocelot Bio is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics designed to significantly improve outcomes for patients with liver disease. The company’s lead clinical candidate, OCE-205, is a peptide therapeutic with a mechanism of action designed to selectively target complications of portal hypertension, such as hepatorenal syndrome with acute kidney injury (HRS-AKI), a serious and life-threatening consequence of end-stage liver disease (ESLD). Ocelot Bio plans to initiate a Phase 2 clinical trial of OCE-205 in the first half of 2022 in HRS-AKI, for which there has been no therapeutic drug innovation in over two decades. The company was founded by leading experts in peptide therapeutic development and is backed by a strong syndicate of investors including Venrock Ventures, RA Capital Management and Vivo Capital. For more information, visit www.ocelotbio.com.
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
FierceMedicalDevices provides breaking news and critical insights into the medical device and diagnostics industries.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Beeline is an early-stage preclinical cell therapy company.
Magellan Midstream Partners, L.P. (NYSE: MMP) is a publicly traded partnership that primarily transports, stores and distributes refined petroleum products and crude oil. The partnership owns the longest refined petroleum products pipeline system in the country, with access to nearly 50% of the nation’s refining capacity, and can store nearly 100 million barrels of petroleum products such as gasoline, diesel fuel and crude oil.
Memgen is developing viral immunotherapies to harness the power of the immune system to cure cancer and protect people from COVID-19
Numira Biosciences provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models.
Hospital Corporation of America (HCA) provides healthcare services in locally managed facilities in 20 states in the U.S. and England.
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
Anodyne Nanotech, Inc. is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company’s macroporous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules (such as ibuprofen) for fast and sustained delivery. We pride ourselves on providing a painless experience for all of those involved in the production, delivery, and consumption of medicines.
